Skip to main content
Login
Contact
Subscribe
Search form
Search
The Observer News Enterprise
Home
Forms
News
Sports
Obituaries
Entertainment
Local Guide
Special Sections
Talking About...
Classifieds
Photos
Videos
Games
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Agios Pharmaceuticals
(NQ:
AGIO
)
53.36
USD
UNCHANGED
Streaming Delayed Price
Updated: 5:25 PM EDT, Apr 14, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Agios Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Agios Announces Closing of Oncology Business Sale to Servier
April 01, 2021
From
GlobeNewswire News Releases
Agios Shareholders Approve Sale of Oncology Business to Servier
March 25, 2021
From
GlobeNewswire News Releases
Agios Sponsors Program Promoting Health Literacy for Patients with Sickle Cell Disease
March 18, 2021
From
GlobeNewswire News Releases
XBI, VIR, LGND, AGIO: ETF Outflow Alert
March 10, 2021
Symbols mentioned in this story: XBI, VIR, LGND, AGIO Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Tags
ETFs
From
ETF Channel
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2021
March 01, 2021
Upgrades Loop Capital upgraded the previous rating for Albemarle Corp (NYSE:ALB) from Hold to Buy. In the fourth ...
Tags
WSFS
PLUG
Downgrades
From
Benzinga
Agios Submits Supplemental New Drug Application to FDA for TIBSOVO® (ivosidenib tablets) for Patients with Previously Treated IDH1-Mutant Cholangiocarcinoma
March 01, 2021
From
GlobeNewswire News Releases
Agios Recognizes 14th Annual Rare Disease Day and Raises Awareness of Unmet Needs in Rare Hemolytic Anemias
February 26, 2021
From
GlobeNewswire News Releases
Agios Pharmaceuticals Inc (AGIO) Q4 2020 Earnings Call Transcript
February 25, 2021
AGIO earnings call for the period ending December 31, 2020.
Tags
AGIO
Market News
From
Motley Fool
The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants
February 25, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
AMRN
GH
AERI
From
Benzinga
Agios Reports Fourth Quarter and Full Year 2020 Financial Results
February 25, 2021
From
GlobeNewswire News Releases
Agios to Present at March Investor Conferences
February 23, 2021
From
GlobeNewswire News Releases
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
February 20, 2021
Biotech stocks pulled back along with the broader market in the holiday-shortened week ended Feb 19. Earnings news flow was light before ...
Tags
HBIO
AKBA
GBT
From
Benzinga
The Daily Biotech Pulse: European Regulatory Nod For Xeris, Amicus Falls On Data, 4 IPOs, FDA Decision For Mallinckrodt's StrataGraft Delayed
February 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
Benzinga
ANAB
SEEL
From
Benzinga
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
February 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
SYNH
CGIX
TXG
From
Benzinga
Agios to Webcast Conference Call of Fourth Quarter and Year End 2020 Financial Results on February 25, 2021
February 11, 2021
From
GlobeNewswire News Releases
The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs
February 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
ENLV
CLPT
INSP
From
Benzinga
FBT's Underlying Holdings Could Mean 16% Gain Potential
February 05, 2021
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement
January 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
NDRA
IBB
OMCL
From
Benzinga
Agios Announces Phase 3 ACTIVATE-T Trial of Mitapivat Achieved Primary Endpoint in Adults with Pyruvate Kinase Deficiency Who Are Regularly Transfused
January 26, 2021
From
GlobeNewswire News Releases
Agios Presents Final Data from Phase 3 ClarIDHy Study of TIBSOVO® (ivosidenib tablets) in Patients with Previously Treated IDH1-Mutant Cholangiocarcinoma
January 17, 2021
– Supplemental New Drug Application Planned for Submission in Q1 2021 –
From
GlobeNewswire News Releases
Interesting AGIO Put And Call Options For March 19th
January 15, 2021
Investors in Agios Pharmaceuticals Inc (AGIO) saw new options begin trading this week, for the March 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AGIO...
Tags
Stocks
From
Market News Video
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
January 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
TSHA
Small Cap
FPRX
From
Benzinga
Noteworthy ETF Outflows: XBI, NTLA, AGIO, SAGE
January 14, 2021
Symbols mentioned in this story: XBI, NTLA, AGIO, SAGE Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These...
Tags
ETFs
From
ETF Channel
Agios Highlights 2021 Milestones to Accelerate and Expand Its Genetically Defined Disease Portfolio and Drive Near- and Long-Term Value Creation
January 11, 2021
From
GlobeNewswire News Releases
Notable ETF Outflow Detected - XBI, AGIO, SAGE, IONS
January 05, 2021
Symbols mentioned in this story: XBI, AGIO, SAGE, IONS Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These...
Tags
ETFs
From
ETF Channel
Agios to Present at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021
January 05, 2021
From
GlobeNewswire News Releases
Analysts Anticipate 20% Gains Ahead For The Holdings of FBT
December 31, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Should Investors Consider These Top Biotech Stocks To Buy? 3 Names To Watch
December 23, 2020
Tags
Market News
From
StockMarket.com
4 Reasons Agios' Oncology Deal Should Please Investors
December 22, 2020
Agios' newly revamped business strategy is an extreme departure from the company's original mission, but it's a great deal for shareholders.
Tags
Market News
AGIO
RPRX
From
Motley Fool
82 Biggest Movers From Yesterday
December 22, 2020
Gainers Big Rock Partners Acquisition Corp. (NASDAQ: BRPA) shares surged 60.4% to close at $24.60 on Monday. Nantkwest Inc ...
Tags
MWK
EYEG
CLSK
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.